Managers / Q4 2018 · view latest →
Casdin Capital, LLC
CIK 0001534261 · 1350 AVENUE OF THE AMERICAS, SUITE 2600, NEW YORK, NY, 10019 · 212-554-4952
Reported Value
$585M
Q4 2018
Positions
31
Filings on Record
33
2019–present window
Filed
Feb 13, 2019
original filing
Summary
Casdin Capital, Llc reported $585M in U.S.-listed holdings across 31 positions for Q4 2018.
Its largest position, Loxo Oncology, represents 8.6% of the portfolio.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q4 2018
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.3B | 40 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.6B | 38 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.2B | 32 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.1B | 33 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.2B | 44 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.5B | 39 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.5B | 35 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.3B | 38 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.3B | 37 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.0B | 38 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $904M | 40 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.1B | 41 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.2B | 41 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.29T | 46 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.5B | 37 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.2B | 40 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.2B | 47 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $3.5B | 53 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $4.0B | 54 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $3.9B | 54 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $3.4B | 48 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $3.4B | 52 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.2B | 45 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.7B | 42 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $942M | 38 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.1B | 32 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019REVEALED | $1.74T | 59 | Nov 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.07T | 31 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $910M | 29 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $585M | 31 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.